Physician

Ashley Michelle Whyte-Rayson, M.D.

According to 2025 Medicare claims, Ashley Whyte-Rayson, M.D. (NPI: 1841556388) practices neurology in the Greeley, CO market, with the plurality of this provider's patient population coming from Weld, CO. This provider's primary affiliated billing organization is POUDRE VALLEY MEDICAL GROUP, LLC (NPI: 1366763260; TIN: 800348943) and primary practice location at 80634-5474. Whyte-Rayson is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604), Banner Network Colorado, LLC (ACO ID: A4768), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Whyte-Rayson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 324 traditional Medicare patients, billed 5,357 HCPCS/CPT codes, and received $82,773 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 2,059 prescription claims across 418 beneficiaries totaling $1,145,196 in drug costs, led by Gammagard Liquid (Immun Glob G(Igg)/Gly/Iga Ov50). 2023 DME data shows 23 claims. Open Payments data shows 1 records totaling $25. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $15,933 to $82,773. Similarly, Part D prescription costs have risen steadily, from $16,528 to $1,145,196. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $264,852 to $14,412.